Non-Small Cell Lung Cancer (NSCLC): An Update

Abstract

Non-Small Cell lung Cancer can be treated with survival benefit providing better quality of life by
applying new chemotherapeutic dosing schemes. Though Surgery and Radiotherapy provide
good results in non small cell lung cancer, most of the patients turn up to doctors in advanced
stages where these facilities can not be offered properly. Combination chemotherapy with
carboplatin or cisplatin with Taxotere and Gemcirabine is now a better option. Chemotherapy
with carboplatin, Gemcirabine, Taxotere and Novelbine is also a better dosing schemes.

doi: 10.3329/taj.v15i2.3923

TAJ December 2002; Vol.15(2): 115-118